Bioisostere Fragment Swapping for Multi-Dimensional Toxicity Prediction

The patent creates virtual copies of molecules through graph neural network representations and uses in silico toxicity prediction models to simulate physical testing. This allows comprehensive toxicity characterization across multiple dimensions without actual physical synthesis, significantly reducing time while maintaining predictive accuracy through sophisticated computational modeling.

The system performs preliminary toxicity screening using machine learning models before physical synthesis is considered. By predicting toxicity early in the drug discovery process using molecular graphs and trained models, the system identifies promising candidates without time-consuming physical testing, allowing focused resource allocation to the most promising compounds.

The patent replaces physical molecules with their digital twins represented as molecular graphs. These graph representations capture all necessary chemical information and can be processed infinitely without consuming additional physical resources. The graph neural networks process these digital copies to predict toxicity with high accuracy, eliminating the need for repeated physical synthesis and testing.

The patent substitutes the mechanical and chemical processes of physical synthesis and wet-lab testing with computational algorithms. Graph neural networks and machine learning models perform toxicity predictions through mathematical operations on molecular graph data, replacing resource-intensive physical experiments with efficient computational procedures that consume minimal resources.

The patent develops a universal graph neural network framework that can predict multiple toxicity dimensions simultaneously from a single molecular graph input. The system integrates diverse toxicity endpoints (cytotoxicity, hepatotoxicity, cardiotoxicity, etc.) into a unified predictive model, allowing comprehensive multi-dimensional toxicity characterization without requiring separate testing protocols for each dimension.

The patent adds the dimension of computational predictivity to traditional toxicity testing. By incorporating machine learning models that process molecular graphs and predict toxicity across multiple dimensions, the system transforms single-point experimental measurements into comprehensive toxicity profiles spanning numerous biological endpoints, effectively adding dimensional depth to toxicity characterization.

The patent performs preliminary training of graph neural network models on extensive datasets of known molecule-toxicity relationships before deployment. This pre-training establishes accurate structure-toxicity mappings that enable fast predictions while maintaining high accuracy. The models learn from historical data to capture complex structure-activity relationships, ensuring reliable predictions when processing new molecules at high speed.

The patent uses graph representations as accurate copies of molecular structures that preserve all chemically relevant information. These graph copies include atomic compositions, bonding patterns, and structural features that are critical for toxicity prediction. By processing these information-rich graphical copies through neural networks, the system maintains prediction accuracy while achieving computational speed far exceeding physical experimentation.